Primary Record
Cabozantinib
- In stock
- 2,716 g
- Purity
- 99.6 %
- CAS
- 849217-68-1
Compound Identifiers & Properties
- CAS
- 849217-68-1
- PubChem CID
- 25102847
- SMILES
- COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F
- Canonical SMILES
- COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC
Names & Synonyms
- Cabozantinib
- 849217-68-1
- Cometriq
- Cabometyx
- cabozantinibum
- Carbozantinib
- XL-184 free base
- XL184
- Cabozantinib-d6
- XL-184
- Cabozantinib malate
- Cabometyx (TN)
- Cabozantinib [USAN]
- Cometriq (TN)
- XL 184
- XL184 free base
- Cabozantinib S-malate
- Cabozantinib/XL184
- Cabozantinib (USAN)
- XL184 cpd
- BMS-907351
- Cabozantinib XL-184
- Cabozantinib, XL184
- Cabozantinib (Standard)
- Cabozantinib [USAN:INN]
- RefChem:57604
- BMS 907351
- cabozantinib (S)-malate
- Cabozantinib (free base)
- CABOZANTINIB [MI]
- Cabozantinib (XL-184)
- Cabozantinib (XL184, BMS-907351)
- CABOZANTINIB [INN]
- MFCD20926324
- cc-10
- CHEBI:72317
- D0IQ6P
- UNII-1C39JW444G
- 1C39JW444G
- A1JS8
- CABOZANTINIB [VANDF]
- BMS-907351 FREE BASE
- C28H24FN3O5
- CABOZANTINIB [WHO-DD]
- SCHEMBL360795
- DTXSID10233968
- BMS907351
- ONIQOQHATWINJY-UHFFFAOYSA-N
- GTPL5887
- orb1305297
- Cabozantinib (BMS-907351)
- CHEMBL2105717
- SCHEMBL29351408
- DTXCID40156459
- EX-A075
- L01XE26
- QCR-122
- SYN1138
- XL184 free base - Cabozantinib
- BCPP000308
- GLXC-90066
- HMS3654G06
- HMS5079K09
- XL-184 free base (Cabozantinib)
- AOB87755
- BCP02591
- 849217-68-1 (free base)
- ABP000796
- BDBM50021574
- EBC-17137
- HY-13016R
- NP3655
- NSC761068
- NSC800066
- s1119
- ZINC70466416
- AKOS025142112
- ACN-031542
- BCP9000470
- CCG-264678
- CS-0278
- DB08875
- FD59688
- NSC-761068
- NSC-800066
- RL05229
- SB20062
- SDCCGSBI-0646928.P001
- XL-184 (Cabozantinib,BMS907351)
- XL-184,Cabozantinib, BMS-907351
- N-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- NCGC00263164-01
- NCGC00263164-14
- NCGC00263164-17
- AC-25082
- AS-16277
- BC267213
- BP-43629
- HY-13016
- SC-85393
- SY097158
- XL-184 (Cabozantinib,BMS907351)?
- AB0033751
- DB-023624
- N'-[4-[(6,7-DIMETHOXY-4-QUINOLINYL)OXY]PHENYL]-N-(4-FLUOROPHENYL)-1,1-CYCLOPROPANEDICARBOXAMIDE
- A2977
- FT-0664184
- NS00020240
- SW218093-3
- X7477
- J3.085.595G
- A10996
- D10062
- Q-3907
- AB01565831_02
- A841013
- Q795057
- SR-01000941569
- SR-01000941569-1
- BRD-K51544265-001-01-8
- BRD-K51544265-001-04-2
- BRD-K51544265-001-06-7
- 1-N-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-1-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N-(4-f
- 1,1-Cyclopropanedicarboxamide, N'-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4-fluorophenyl)-
- N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide
- XL 184, XL-184, 1021950-26-4
- 1,1-Cyclopropanedicarboxamide,N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-
- n-(4-((6,7-dimethoxy-4-quinolinyl)oxy)phenyl)-n'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide
- N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl)cyclopropane-1,1- dicarboxamide
- N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- N1-[4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl]-N1'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- 1,1-CYCLOPROPANEDICARBOXAMIDE, N'-(4-((6,7-DIMETHOXY-4-QUINOLINYL)OXY)PHENYL)-N-(4-FLUOROPHENYL)-
- 1,1-Cyclopropanedicarboxamide, N'-(4-((6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4- fluorophenyl)-
- 1,1-Cyclopropanedicarboxamide, N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-
- 1802168-46-2
- 4-[4-[[[1-[(4-Fluorophenyl)aminocarbonyl]cyclopropyl]carbonyl]amino]phenoxy]-6,7-dimethoxyquinoline
- Cabozantinib; N'-?[4-?[(6,?7-?Dimethoxy-?4-?quinolinyl)?oxy]?phenyl]?-?N-?(4-?fluorophenyl)?-1,?1-cyclopropanedicarbox?amide; N'-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide; BMS 907351; N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide
- Cyclopropane-1,1-dicarboxylic acid [4-(6,7-dimethoxy-quinoline-4-yloxy)-phenyl]-amide (4-fluoro-phenyl)-amide
- cyclopropane-1,1-dicarboxylic acid [4-(6,7-dimethoxy-quinoline-4-yloxy)-phenyl]-amide(4-fluoro-phenyl)-amide
- cyclopropane-1,1-dicarboxylic acid[4-(6,7-dimethoxy-quinoline-4-yloxy)-phenyl]-amide (4-fluoro-phenyl)-amide
- N'1-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- N-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N'-(4 fluorophenyl)cyclopropane-1,1-dicarboxamide
- N-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide
- N-[4-[(6,7-Dimethoxyquinolin-4-yl)oxy]phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- N~1~-{4-[(6,7-Dimethoxyquinolin-4-yl)oxy]phenyl}-N'~1~-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide